The paper by Heitjan et al [11] provides very interesting and useful review of the methods for predicting patient enrollment and event counts in clinical trials. The aim of this letter is to raise an additional discussion on some points and to provide readers with more comprehensive information and clarification of particular methods/techniques.First, it would be useful to specify that there are two basic stages in predicting patient enrollment and various events: 1. Start-up (baseline) prediction before trials starts and therefore there is no real trial data available yet, and 2. Interim prediction where it is possible to use real trial data and update (re-project) trial behaviour for the remaining period. At both stages, good predictive techniques potentially can use similar models, only input parameters will be evaluated differently.Since the trial start-up stage is not reflected in detail in [11], it seems expedient to devote some time to this.